Position >  > English > About Us >

About Us

About Us
 

Company Overview

         SinoFour Automation Technology (Shanghai) Co., Ltd. was established in 2014 and obtained the Certificate of High and New Technology Enterprise in 2019. In March 2023, it was recognized as a Specialized and Sophisticated enterprise of Shanghai. In 2020, it was listed on SEE Stock of Shanghai equity custody and trading center, with the stock code of 300371.
         SinoFour has passed the GB/T19001-2016/ISO9001:2015 quality management system certification. It has Grade II qualification for specialized contracting of electronic and intelligent engineering and the SafetyPermits. At present, it has two utility model patents and 33 software copyrights in the pharmaceutical industry. In 2021, Wuhan CtrlTake, a subsidiary, was launched as the engineering technology center in Central China, and became a Siemens (China) certified system integrator in March 2022.
         SinoFour can provide customers in the pharmaceutical, fine chemical and food industries with full life cycle services from conceptual design, project implementation to production and maintenance and provide integrated automation solutions. SinoFour can also undertake automation control EPC project, automation projects conforming to GAMP5 specification and automation projects based on ISA S88 model batch formula management, and also provide customized report services for customers.

Main business areas:

  • General contracting project of automation engineering in pharmaceutical industry;
  • Full life cycle services - conceptual design, project implementation, production maintenance;
  • Integrated automation solutions for the pharmaceutical industry;
  • GAMP5-compliant automation engineering (including hardware / software supply, integration, programming, testing, service);
  • Design and implementation of BATCH (batch) recipe management automation project based on ISAS88;
  • Customized design and development of batch reports, production reports, material and product tracking records;

Major client:

Main achievement:

             Since its establishment, SinoFour has been deeply engaged in the fields of chemical API, biopharmaceutical and fine chemical automatic production lines for many years. In recent four years, it has successively undertaken two general contracting projects of Hiray Pharmaceutical API Automation Project and Qingfeng Pharmaceutical API Automation Project. SinoFour has successively implemented 25 projects, including Suzhou Novartis pharmaceutical Rooster continuous transformation project, BATCH project, CMT continuous production technology project, SCADA project, waste water tank and GMP verification; Chongqing Porton pharmaceutical 304 / 110 / 105 / 306 workshop series DCS and other 18 projects, Dow Chemical BPSA pilot relocation, automatic feeding project control and restructuring and other 15 projects. SinoFour successively implemented and completed the API and biopharmaceutical projects of Yichang dongyangguang and Changzhou Genova. In 2022, it has opened up high-quality customers such as Chongqing Huapont, Hefei Huana Medicion, Pall (China), Sichuan Werlchem, Hwasun Pharma, and has reached lots of project cooperation. In 2023, SinoFour reached cooperation with Shanghai Huilun and Hunan Fangsheng for the first time. 

Our advantage:

1.Technology R & D: industry leading product R & D, design and customization capabilities It has provided many well-known automatic control solutions for pharmaceutical and chemical processes at home and abroad, and obtained a variety of patents and soft rights, such as hydrogenation system, material transfer control system, reactor temperature control, reactor stirring control, powder material transfer device cleaning control, material selection system, solid material grinding system, reactor pressure control, reactor vacuum control, solid preparation vibration screening system, liquid preparation material management system Temperature and humidity control system of clean workshop, etc.
2.SinoFour can undertake the general contracting project of automation engineering in the pharmaceutical industry, and provide overall solutions and full life cycle services; Help customers meet complex challenges and build efficient, flexible and sustainable manufacturing facilities.
3.Team advantages:
(1)Focus on Industry: focus on automation solutions for the pharmaceutical industry, deeply cultivate the field of APIs and biopharmaceuticals, and more than 90% of the main business comes from the pharmaceutical industry;
(2)Excellent professional quality: all employees receive GMP training and have bachelor degree or above.
 

         SinoFour provides high-level automation solutions for pharmaceutical users and one-stop project trusteeship. In the future, SinoFour will continue to focus on the industry, deeply cultivate the API, biopharmaceutical and traditional Chinese medicine markets, and achieve the goal of providing intelligent and digital solutions for pharmaceutical users within three years, aiming to become a leading cloud service provider for smart pharmaceutical companies in China.